In summary, RIPK1 exerts multifaceted effects in AD pathology, contributing to neurofibrillary tangle formation, β-amyloid plaque deposition, neuroinflammation, and transcriptional dysregulation. This evidence concerns the gene RIPK1 and Alzheimer disease.